CONBA: Adenosylcobalamin capsules are expected to win the bid for the 11th batch of national centralized drug procurement

CONBA announced that its wholly-owned subsidiary Hangzhou CONBA Pharmaceutical Co., Ltd. participated in the national organization of the 11th batch of centralized drug procurement. After review, Hangzhou CONBA's adenosylcobalamin capsules are expected to win the bid. The expected bid price for adenosylcobalamin capsules is 3.81 yuan/box, with a planned supply quantity of 8.3224 million capsules to the provinces, including Sichuan, Hubei, and Ningxia. The procurement cycle is 3 years, with an agreed procurement volume of 2.62 million capsules. This successful bid is beneficial for the rapid sales growth of the product and market expansion, which will have a positive impact on the company's future operating performance